Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tianshu Capsule for Migraine
NCT02035111Phase 4Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Mar 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tianshu in migraine (2 arms), sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd. Primary endpoint: Change in the frequency of attack of Migraine Per 4 weeks at Week 16 from baseline. Started Mar 2014; status: completed.
02
Drugs
Tianshu
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02035111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02035111.